ArticleJournal of clinical medicine2020

Nuclear Magnetic Resonance Metabolomics Biomarkers for Identifying High Risk Patients with Extranodal Extension in Oral Squamous Cell Carcinoma.

Cheng-Kun Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.